DPI2, a FIN (ferroptosis-inducing compound), which does not inhibit GPx4 activity but specifically inhibits SLC7A11 expression, consumed 90% of the GSH in BjeLR cells compared to the untreated group
Patients increasingly expect that the products they receive, particularly those related to wellbeing or long-term treatment, are delivered safely, responsibly, and sustainably
Additionally, a high percentage of participants achieved a weight reduction of 5% or more (85% with 5 mg, 89% with 10 mg, and 91% with 15 mg of tirzepatide)
Tirzepatide slows gastric emptying, which means alcohol sits in your stomach longer and absorbs more slowly, then hits harder when it does absorb